Appendix NET                                                                
Previous Topic  Next Topic 

Appendix - NET (SAPXN)


- For resection specimens with well-differentiated neuroendocrine tumors (NET) of low or intermediate grade.  Goblet cell carcinoids, poorly differentiated carcinomas with neuroendocrine features, and small cell carcinomas are not included.


Specimen and Surgical Procedure

Specimen, procedure....................................................................

Specimen integrity.................................................................. intact/fragmented


Tumor

Tumor site...................................................................................

Classify as

- proximal half of appendix

- distal half of appendix

- diffusely involving appendix

- indeterminate

Tumor size...................................................................................

Histologic type................................................................. well-differentiated NET

Histologic grade............................................................................

Mitotic rate................................................................................... __/10 hpf

Ki-67 labeling index....................................................................... __%

Microscopic tumor extension...........................................................

Lymph-vascular invasion.............................................................. present/absent


Final margins

Nearest margin............................................................................

Distance from specified margin to tumor.........................................

Distance from mesenteric (mesoappendiceal) margin*......................

*if not already listed as the "Nearest margin" above


Proximal resection margin............................................... positive/negative

Other margin(s) (if applicable; please specify).................... positive/negative


Lymph Nodes

Regional lymph nodes (involved/examined)....................................... __/__


Pathologic stage........................................................................ pT__N__M__


Endocrine


Comments


Staging


Click here to leave feedback